ClinicalTrials.Veeva

Menu

Fluoroscopic Analysis of Total Knee Replacement With a Kinematic Retaining or a Posterior Stabilized Design

L

Limacorporate

Status

Completed

Conditions

Total Knee Replacement

Treatments

Device: Physica KR
Device: Physica PS

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The aim of this study is to evaluate the in vivo kinematics of TKA performed with two different prosthesis: a kinematic retaining (Physica KR) and a posterior-stabilized (Physica PS) design by means of fluoroscopic analysis during activities of daily living (rising from a chair, stairs climbing, leg extension). In comparison with asymptomatic knee. Patterns of femoral rollback will be analyzed to assess if they are motor-task dependent and correlated with clinical outcomes.

Enrollment

34 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients submitted to Total knee arthroplasty (TKA) with Physica KR or PS;
  2. Patients with an appropriate initial fixation and stability of the knee prosthesis;
  3. Patients achieving a minimum flexion of 100° or a Knee Society Score (KSS) ≥ 65 (fair/good postoperative outcome) at 6-month follow-up;
  4. Patients affected by primary or secondary Osteoarthritis (OA) before surgery;
  5. Patients who understand the requirements of the study and are willing and able to comply with activities required for fluoroscopic examination;
  6. Patients who have signed the Ethics Committee approved study-specific Informed Consent Form.

Exclusion criteria

  1. Patients with misalignment or axial malrotation of the knee prosthesis;
  2. Patients not able to achieve a minimum flexion of 100° or with a KSS Knee Score ≤ 65 points at 6-month follow-up;
  3. Patients who had or have planned a surgery on their uninvolved knee within a year;
  4. Muscular insufficiency or absence of muscololigamentous supporting structures required for adequate soft tissue balance;
  5. Patients who have significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery and evaluation;
  6. Patients who have neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device;
  7. Any psychiatric illness that would prevent comprehension of the details and nature of the study;
  8. Participation in any experimental drug/device study within the 6 months prior to the screening visit
  9. Female patients who are pregnant, nursing, or planning a pregnancy due to x-rays exposition.

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

34 participants in 2 patient groups

Physica KR
Other group
Description:
Patients who have received a Physica KR total knee implant.
Treatment:
Device: Physica KR
Physica PS
Other group
Description:
Patients who have received a Physica PS total knee implant.
Treatment:
Device: Physica PS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems